Address
Email address
Phone number
Website
http://www.bait.eeHome - Bait PartnerWhat Our Clients Have to Say About Us Savonlinna hospital has a long-term co-operation on developing ORNet Surgery products and we suggest Bait Partner to other potential users. Bait Partner has created according to the requirement of the
Name
Bait Partner OÜ
Registry code
10973181
VAT number
EE100858521
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.09.2003 (21)
Financial year
01.01-31.12
Capital
3 834.00 €
Activity
32509 - Manufacture of other medical and dental instruments and supplies
578 604 €
61 942 €
11%
2 549 €
(estimate is approximate)
216 155 €
8
Submitted
No tax arrears
29%
22%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Inga Moreva 30.03.1972 (52) | - | Board member | Direct ownership | |
| John Erik Lindman 25.10.1958 (66) | - | Board member | - | |
| OSAÜHING VOLBEKO CONSULT 10569480 | - | - | - | Founder |
| 2019 22.06.2020 | 2020 11.06.2021 | 2021 06.05.2022 | 2022 30.05.2023 | 2023 24.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 556 385 € | 538 024 € | 390 216 € | 487 643 € | 578 604 € |
| Net profit (loss) for the period | 66 815 € | 45 957 € | 13 828 € | 59 442 € | 61 942 € |
| Profit Margin | 12% | 9% | 4% | 12% | 11% |
| Current Assets | 290 171 € | 267 838 € | 234 257 € | 255 497 € | 270 526 € |
| Fixed Assets | 7 496 € | 33 559 € | 27 812 € | 20 473 € | 13 545 € |
| Total Assets | 297 667 € | 301 397 € | 262 069 € | 275 970 € | 284 071 € |
| Current Liabilities | 79 129 € | 61 807 € | 53 515 € | 63 826 € | 67 916 € |
| Non Current Liabilities | - | 4 864 € | 0 € | - | - |
| Total Liabilities | - | 66 671 € | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 218 538 € | 234 726 € | 208 554 € | 212 144 € | 216 155 € |
| Employees | 8 | 12 | 6 | 10 | 8 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 147 485.59 € | 49 163.77 € | 36 428.75 € | 9 |
| 2023 Q4 | 102 932.83 € | 35 588.14 € | 34 671.56 € | 9 |
| 2023 Q3 | 141 046.31 € | 35 758.94 € | 34 358.93 € | 11 |
| 2023 Q2 | 162 568.23 € | 35 938.16 € | 32 179.28 € | 12 |
| 2023 Q1 | 132 275.78 € | 28 690.13 € | 26 450.65 € | 11 |
| 2022 Q4 | 149 333.63 € | 25 355.77 € | 26 634.19 € | 11 |
| 2022 Q3 | 140 136 € | 31 055.79 € | 26 089.51 € | 11 |
| 2022 Q2 | 102 280.42 € | 20 310.09 € | 20 648.84 € | 11 |
| 2022 Q1 | 116 654.42 € | 21 338.36 € | 18 951.57 € | 10 |
| 2021 Q4 | 96 661.57 € | 15 105.69 € | 15 754.33 € | 10 |
| 2021 Q3 | 109 088.57 € | 24 275.58 € | 24 084.26 € | 9 |
| 2021 Q2 | 98 695.03 € | 24 933.86 € | 23 666.92 € | 9 |
| 2021 Q1 | 149 507.99 € | 24 645.31 € | 21 712.98 € | 9 |
| 2020 Q4 | 145 852.13 € | 22 421.96 € | 22 057.28 € | 8 |
| 2020 Q3 | 180 604.92 € | 24 095.56 € | 25 314.8 € | 8 |
| 2020 Q2 | 198 990.89 € | 24 822.5 € | 23 059.04 € | 12 |
| 2020 Q1 | 140 205.72 € | 27 798.06 € | 25 190.87 € | 12 |
